Cargando…

Recent advances in understanding/management of non-alcoholic steatohepatitis

Non-alcoholic steatohepatitis (NASH) can lead to advanced fibrosis, hepatocellular carcinoma, and end-stage liver disease requiring liver transplantation. A myriad of pathways and genetic influence contribute to NASH pathogenesis and liver disease progression. Diagnosing patients with NASH and advan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pacana, Tommy, Sanyal, Arun J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Faculty of 1000 Ltd 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371374/ https://www.ncbi.nlm.nih.gov/pubmed/25926979 http://dx.doi.org/10.12703/P7-28

Ejemplares similares

Recent advances in understanding and managing non-alcoholic fatty liver disease
por: Albhaisi, Somaya, et al.
Publicado: (2018)

Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval Pathway
por: Filozof, Claudia, et al.
Publicado: (2015)

Review article: the impact of liver‐directed therapies on the atherogenic risk profile in non‐alcoholic steatohepatitis
por: Connelly, Margery A., et al.
Publicado: (2020)

Metabolomic Profiling to Identify Predictors of Response to Vitamin E for Non-Alcoholic Steatohepatitis (NASH)
por: Cheng, Jianfeng, et al.
Publicado: (2012)

Combined alcoholic and non-alcoholic steatohepatitis
por: Ntandja Wandji, Line Carolle, et al.
Publicado: (2020)

Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitis
por: Sanyal, Arun J., et al.
Publicado: (2023)

Drug discovery and treatment paradigms in nonalcoholic steatohepatitis
por: Noureddin, Mazen, et al.
Publicado: (2019)

Recent Insights into the Biomarkers, Molecular Targets and Mechanisms of Non-Alcoholic Steatohepatitis-Driven Hepatocarcinogenesis
por: Kakehashi, Anna, et al.
Publicado: (2023)

Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis
por: Luo, Yi, et al.
Publicado: (2021)

Non-Alcoholic Steatohepatitis: Pathogenesis and Clinical Management
por: Salomone, Federico, et al.
Publicado: (2015)

Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management
por: Cholankeril, George, et al.
Publicado: (2017)

Advances and Emerging Therapies in the Treatment of Non-alcoholic Steatohepatitis
por: Brennan, Paul N, et al.
Publicado: (2022)

A new preclinical model of western diet‐induced progression of non‐alcoholic steatohepatitis to hepatocellular carcinoma
por: Green, Christopher D., et al.
Publicado: (2022)

Recent advances in the understanding and management of ARDS
por: Peck, Tyler J, et al.
Publicado: (2019)

Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science
por: Brar, Gurmehr, et al.
Publicado: (2019)

Immunological Mechanisms in the Pathophysiology of Non-Alcoholic Steatohepatitis
por: Vonghia, Luisa, et al.
Publicado: (2013)

Presence and Implications of Sarcopenia in Non-alcoholic Steatohepatitis
por: Habig, Gregory, et al.
Publicado: (2021)

Lipotoxicity as the Leading Cause of Non-Alcoholic Steatohepatitis
por: Branković, Marija, et al.
Publicado: (2022)

Metabolomic Predictors of Non-alcoholic Steatohepatitis and Advanced Fibrosis in Children
por: Kordy, Kattayoun, et al.
Publicado: (2021)

Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma
por: Rios, Rafael S., et al.
Publicado: (2021)

Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis
por: Baker, Susan S., et al.
Publicado: (2010)

Recent advances in understanding and managing cholestasis
por: Wagner, Martin, et al.
Publicado: (2016)

Recent advances in understanding and managing asthma
por: Loo, Su-Ling, et al.
Publicado: (2016)

Recent advances in understanding and managing urolithiasis
por: Strohmaier, Walter L.
Publicado: (2016)

Recent advances in understanding and managing chordomas
por: Youssef, Carl, et al.
Publicado: (2016)

Recent advances in understanding and managing diverticulitis
por: Severi, Carola, et al.
Publicado: (2018)

Recent advances in understanding and managing dystonia
por: Tisch, Stephen
Publicado: (2018)

Recent advances in managing/understanding meningioma
por: Shaikh, Nawal, et al.
Publicado: (2018)

Recent advances in managing and understanding enuresis
por: Van Herzeele, Charlotte, et al.
Publicado: (2017)

Recent advances in understanding and managing adenomyosis
por: Vannuccini, Silvia, et al.
Publicado: (2019)

Recent advances in understanding and managing sepsis
por: Berg, Daniela, et al.
Publicado: (2018)

Recent advances in the understanding and management of mucormycosis
por: Pilmis, Benoit, et al.
Publicado: (2018)

Recent advances in understanding and managing rosacea
por: Buddenkotte, Joerg, et al.
Publicado: (2018)

Recent advances in managing and understanding uveitis
por: Chen, Shih-Chou, et al.
Publicado: (2017)

Recent advances in understanding and managing gout
por: Igel, Talia F., et al.
Publicado: (2017)

Recent Advances in Understanding and Managing Cardiomyopathy
por: Alvarez, Paulino, et al.
Publicado: (2017)

Recent advances in understanding and managing hypoparathyroidism
por: Rubin, Mishaela R.
Publicado: (2020)

Recent advances in understanding and managing acne
por: Kurokawa, Ichiro, et al.
Publicado: (2020)

Recent advances in understanding and managing leiomyosarcomas
por: Duffaud, Florence, et al.
Publicado: (2015)

Recent advances in understanding and managing rhabdomyosarcoma
por: Hiniker, Susan M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2stkef541alnm01df0v5ptha9i